Dipika Bansal, MD, DM

National Institute of Pharmaceutical Education and Research (NIPER). S.A.S. Nagar, India

Poster(s):

• (069) Isatuximab Adverse Event Monitoring: A Safety Meta-Analysis of Randomized Controlled Trials and Refining Signals through Pharmacovigilance Analysis
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (095) Gastrointestinal Adverse Events with Glucagon-like Peptide-1 Receptor Agonist in Type 2 Diabetes: A Comprehensive Meta-analysis of Randomised Controlled Trials and Refining Signals through Pharmacovigilance Analysis.
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (314) Mapping the Epidemiological burden of active and lifetime epilepsy in Asian Countries: A Systematic review and Meta-analysis
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (CSPOT42) Stem Cell Therapy in Avascular Necrosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST